Non-angiogenic tumours and their influence on cancer biology
Solid tumours need a blood supply, and a large body of evidence has previously suggested that they can grow only if they induce the development of new blood vessels, a process known as tumour angiogenesis. On the basis of this hypothesis, it was proposed that anti-angiogenic drugs should be able to...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Springer Nature
2018
|
| _version_ | 1826300139762876416 |
|---|---|
| author | Donnem, T Reynolds, A Kuczynski, E Gatter, K Vermeulen, P Kerbel, R Harris, A Pezzella, F |
| author_facet | Donnem, T Reynolds, A Kuczynski, E Gatter, K Vermeulen, P Kerbel, R Harris, A Pezzella, F |
| author_sort | Donnem, T |
| collection | OXFORD |
| description | Solid tumours need a blood supply, and a large body of evidence has previously suggested that they can grow only if they induce the development of new blood vessels, a process known as tumour angiogenesis. On the basis of this hypothesis, it was proposed that anti-angiogenic drugs should be able to suppress the growth of all solid tumours. However, clinical experience with anti-angiogenic agents has shown that this is not always the case. Reports of tumours growing without the formation of new vessels can be found in the literature dating back to the 1800s, yet no formal recognition, description and demonstration of their special biological status was made until recently. In 1996, we formally recognized and described non-angiogenic tumours in lungs where the only blood vessels present were those originating from normal lung tissue. This is far from an isolated scenario, as non-angiogenic tumour growth has now been observed in tumours of many different organs in both humans and preclinical animal models. In this Opinion article, we summarize how these tumours were discovered and discuss what we know so far about their biology and the potential implications of this knowledge for cancer treatment. |
| first_indexed | 2024-03-07T05:12:38Z |
| format | Journal article |
| id | oxford-uuid:dc143298-2e3c-4cf2-9f6c-9674f06d60d7 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:12:38Z |
| publishDate | 2018 |
| publisher | Springer Nature |
| record_format | dspace |
| spelling | oxford-uuid:dc143298-2e3c-4cf2-9f6c-9674f06d60d72022-03-27T09:15:14ZNon-angiogenic tumours and their influence on cancer biologyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dc143298-2e3c-4cf2-9f6c-9674f06d60d7EnglishSymplectic Elements at OxfordSpringer Nature2018Donnem, TReynolds, AKuczynski, EGatter, KVermeulen, PKerbel, RHarris, APezzella, FSolid tumours need a blood supply, and a large body of evidence has previously suggested that they can grow only if they induce the development of new blood vessels, a process known as tumour angiogenesis. On the basis of this hypothesis, it was proposed that anti-angiogenic drugs should be able to suppress the growth of all solid tumours. However, clinical experience with anti-angiogenic agents has shown that this is not always the case. Reports of tumours growing without the formation of new vessels can be found in the literature dating back to the 1800s, yet no formal recognition, description and demonstration of their special biological status was made until recently. In 1996, we formally recognized and described non-angiogenic tumours in lungs where the only blood vessels present were those originating from normal lung tissue. This is far from an isolated scenario, as non-angiogenic tumour growth has now been observed in tumours of many different organs in both humans and preclinical animal models. In this Opinion article, we summarize how these tumours were discovered and discuss what we know so far about their biology and the potential implications of this knowledge for cancer treatment. |
| spellingShingle | Donnem, T Reynolds, A Kuczynski, E Gatter, K Vermeulen, P Kerbel, R Harris, A Pezzella, F Non-angiogenic tumours and their influence on cancer biology |
| title | Non-angiogenic tumours and their influence on cancer biology |
| title_full | Non-angiogenic tumours and their influence on cancer biology |
| title_fullStr | Non-angiogenic tumours and their influence on cancer biology |
| title_full_unstemmed | Non-angiogenic tumours and their influence on cancer biology |
| title_short | Non-angiogenic tumours and their influence on cancer biology |
| title_sort | non angiogenic tumours and their influence on cancer biology |
| work_keys_str_mv | AT donnemt nonangiogenictumoursandtheirinfluenceoncancerbiology AT reynoldsa nonangiogenictumoursandtheirinfluenceoncancerbiology AT kuczynskie nonangiogenictumoursandtheirinfluenceoncancerbiology AT gatterk nonangiogenictumoursandtheirinfluenceoncancerbiology AT vermeulenp nonangiogenictumoursandtheirinfluenceoncancerbiology AT kerbelr nonangiogenictumoursandtheirinfluenceoncancerbiology AT harrisa nonangiogenictumoursandtheirinfluenceoncancerbiology AT pezzellaf nonangiogenictumoursandtheirinfluenceoncancerbiology |